You are here: Industry Insights > Sanofi

News List

Sanofi’s Kevzara will be funded for NHS use pharmatimes
September 25, 2017
Some patients with rheumatoid arthritis living in England and Wales should get ‘routine’ NHS access to Sanofi’s Kevzara after cost regulators issued draft guidelines deeming the drug cost effective.
Sanofi, NIH Researchers Develop "Three-In-One" Antibodies as Potential Intervention for HIV/AIDS americanpharmaceuticacreview
September 22, 2017
Natural antibodies recognize a single target on a foreign protein. In this study, antibodies were engineered to recognize three different target sites in one molecule.
Sanofi, Alnylam’s RNAi therapeutic smashes PhIII targets pharmatimes
September 22, 2017
An investigational RNAi therapeutic being developed by Sanofi Genzyme and Alnylam Pharmaceuticals has hit targets in a late stage trial involving patients with hereditary ATTR amyloidosis with polyneuropathy.
Sanofi and Regeneron's Dupixent scores a potential sales boost as AbbVie candidate threatens fiercepharma
September 19, 2017
Sanofi and Regeneron, whose Dupixent is slated to reach peak sales of at least $4 billion, have continued pumping out new data ion the hope of getting it there sooner rather than later.
Sanofi and Regeneron announce results for Dupixent (dupilumab) biospectrumasia
September 19, 2017
The results of the study was presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress
Sanofi, Lexicon trot out more data backing SGLT1/2 medication sotagliflozin in Type 1 diabetes fiercebiotech
September 15, 2017
LISBON, Portugal—A cadre of SGLT2 meds may have beaten Sanofi and Lexicon Pharmaceuticals to that fast-growing market, but the partners aim to carve out a place for their experimental drug sotagliflozin in Type 1 diabetes.
Sanofi/Regeneron new asthma data bolstered by potential indications pharmafile
September 14, 2017
Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but the expectation has heaped pressure onto every release of data the companies release.
Dupixent severe asthma results should propel Sanofi, Regeneron drug to billions more in sales fiercepharma
September 12, 2017
Dupixent, the Sanofi and Regeneron drug already on a blockbuster arc in atopic dermatitis, has returned significant results in patients with severe asthma
Sanofi launches Combiflam ICYHOT expressbpd
September 12, 2017
The over-the-counter (OTC) product is available in two formats – gel and spray
Sanofi, Shire, Vertex and more back first-ever rare disease film festival fiercepharma
August 31, 2017
Lucas DeFabio stars in one of the films set to be shown at the new rare-disease film festival, co-founded by his father, Daniel DeFabio, and Bo Bigelow.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page